Evidence map›Paper›PMID 37064536›Full record

ArticleInflammatory intestinal diseases2023

The Impact of Concomitant Ulcerative Colitis on the Clinical Course in Patients with Primary Sclerosing Cholangitis: An Investigation Using a Nationwide Database in Japan.

Rintaro Moroi, Kota Yano, Kunio Tarasawa, Yusuke Shimoyama, Takeo Naito, Hisashi Shiga, Shin Hamada, Yoichi Kakuta, Kiyohide Fushimi, Kenji Fujimori and 2 more

Open access · goldAbstract read
In one paragraph

Article in Inflammatory intestinal diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Rintaro MoroiDivision of Gastroenterology, Tohoku University Hospital, Sendai, Japan.
Kota YanoDivision of Gastroenterology, Tohoku University Hospital, Sendai, Japan.
Kunio TarasawaDepartment of Health Administration and Policy, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yusuke ShimoyamaDivision of Gastroenterology, Tohoku University Hospital, Sendai, Japan.
Takeo NaitoDivision of Gastroenterology, Tohoku University Hospital, Sendai, Japan.
Hisashi ShigaDivision of Gastroenterology, Tohoku University Hospital, Sendai, Japan.
Shin HamadaDivision of Gastroenterology, Tohoku University Hospital, Sendai, Japan.
Yoichi KakutaDivision of Gastroenterology, Tohoku University Hospital, Sendai, Japan.
Kiyohide FushimiDepartment of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medicine, Bunkyo, Japan.
Kenji FujimoriDepartment of Health Administration and Policy, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yoshitaka KinouchiDivision of Gastroenterology, Tohoku University Hospital, Sendai, Japan.
Atsushi MasamuneDivision of Gastroenterology, Tohoku University Hospital, Sendai, Japan.
Tohoku University Hospital · JPTohoku University · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introoduction: Primary sclerosing cholangitis (PSC) is a rare disease, especially in Asian countries. PSC often develops during ulcerative colitis (UC). Little is known about the severity of PSC in patients with UC. Thus, this study aimed to investigate the impact of concomitant UC on the clinical course of patients with PSC using a nationwide database in Japan. Methods: We collected data on patients who were admitted for PSC using a nationwide database and divided eligible admissions according to concomitant UC (PSC-UC group vs. PSC-alone group). We conducted propensity score matching and compared the rates of liver transplantation, biliary drainage, and other clinical events between the two groups. We also conducted a multivariate analysis to identify the clinical factors that affect biliary drainage, cholangiocarcinoma, and liver transplantation. Results: We enrolled 672 patients after propensity score matching. The rate of liver transplantation in the PSC-UC group was lower than that in the PSC-alone group (2.2 vs. 5.4%, Discussion: Concomitant UC in patients with PSC may decrease the risk of liver transplantation. The milder disease activity of PSC with UC is more likely compared to that of PSC without UC.

Indexed as

Biliary drainageCholangiocarcinomaLiver transplantationPrimary sclerosing cholangitisUlcerative colitis

Identifiers

PMID37064536
PMCPMC10091018
OpenAlexW4318773771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.